/C O R R E C T I O N -- Atmofizer Technologies Inc./

In the news release, ATMOFIZER TECHNOLOGIES INC. ANNOUNCES FOX NEWS INTERVIEWS WITH BOARD MEMBER DR JOSHUA HELMAN, issued 05-Jul-2023 by Atmofizer Technologies Inc. over CNW, we are advised by the company that the company website in the second-last paragraph should be spelled "www.atmofizer.com" and not "www.atmofixer.com," as issued inadvertently. The complete, corrected release follows:

ATMOFIZER TECHNOLOGIES INC. ANNOUNCES FOX NEWS INTERVIEWS WITH BOARD MEMBER DR JOSHUA HELMAN

VANCOUVER, BC, July 5, 2023 /PRNewswire/ - Atmofizer Technologies Inc. (the "Company" or "Atmofizer") (CSE: ATMO) (OTCQB: ATMFF) is pleased to announce that a series of interviews with Board member Dr. Joshua Helman took place between June 8^th, 2023 and June 10^th, 2023 on a number of Fox News and Fox Business shows to discuss the impact of the Canadian wildfires has on air quality and associated health risks. Dr. Helman appeared as an air quality expert on these shows. Dr. Helman was also able to highlight the benefits of Atmofizer's technology to agglomerate ultra fine particles like those that can be found in wildfire smoke. This agglomeration technology has been implemented in the company's patented A500 air purifiers and is currently under development in its HVAC integrated unit that is expected to be launched later in 2023.

Quote from Dr. Joshua Helman "The current wildfire smoke in the air is quite dangerous as it includes fine particulate that can be inhaled that can be absorbed in the lungs. Wildfire smoke is ten times as dangerous as normal air pollution is. These extremely small particles which are smaller than the width of a hair is dangerous because once you breathe them into your lungs, they go into your bloodstream and then spread to brain, heart, kidneys liver and other organs. The people who are most vulnerable to this threat are the young and older people. And those with chronic conditions. If you are in an area with poor air quality, I strongly recommend that you remain indoors and have a good home air filtration system. Atmofizer's technology uses sound wave technology that captures these extremely fine particles and uses UV light to neutralize them."

Links to Dr. Helman's interviews can be found below.

https://www.foxnews.com/video/6329006894112

https://www.streamslist.com/Player?ShareId=ce787e21-edef-4592-aea5-f954b6eb8b21&PortalId=3cddb705-54f4-45f7-97d3-ae049ae4e988&EmailAddress=gallen@metromonitor.com&FileId=6a33f765-6ca0-430f-8c1c-7ed2b5820d6c

https://www.foxnews.com/video/6329172567112

Additionally, as the result of Dr. Helman's interviews and coverage of the Company's A500 air purifier, the A500 was featured in the House and Home section of Fox news on June 9^th, 2023 as one of the "best air purifiers to buy for wildfire smoke and more according to experts."

https://www.foxnews.com/lifestyle/best-air-purifiers-buy-wildfire-smoke-more-according-experts

The A500 air purifier is available to purchase from the Company's website www.atmofizer.com

The Company also announces today the departure of Whit Pepper as Chief Commercial Officer. The Board thanks Whit for his contribution.

About Atmofizer Technologies Inc.

Atmofizer's consumer and industrial solutions are based on its patent-protected and patent pending technology for ultrafine particle agglomeration and neutralization. This capability creates a revolutionary and more efficient method for addressing the wide range of dangerous nano-scale particles, viruses and bacteria that are too small to be effectively managed by conventional HEPA filters and ultraviolet lights. Atmofizer plans to disrupt the air treatment industry by improving air safety and purification efficiency while lowering customers' operational costs.

Atmofizing air refers to the process of using ultrasonic acoustic waves to agglomerate (cluster together) small particles into a larger target that is then radiated by ultraviolet light to neutralize their harmful properties. Using units that atmofize air in tandem with HEPA filters can make the HEPA filters work more efficiently, enable the use of a less-powerful filter and result in a cleaner and longer-lasting filter that reduces operating costs and is less of a health hazard to clean or replace.

Atmofizer is patent-pending and patent-protected sole source of technology to atmofize air and is applying its proprietary technology in consumer and industrial air purification products currently manufactured under the Atmofizer brand, as well as in retail and commercial devices produced by other companies that integrate Atmofizer technology into their own products under license. Atmofizer's owned and licensed product lines include wearable, portable and mobile use for personal air treatment, as well as larger systems to handle higher air volumes for commercial, industrial, institutional and residential applications.

Forward-Looking Information

This press release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company's ability to comply with all applicable laws and governmental regulations relating to its commercial products; the ability of the Company to protect its intellectual property; impacts to the business and operations of the Company due to the COVID-19 pandemic; the conflict in eastern Europe; having only a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company's reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company's continuous disclosure documents, which have been filed on SEDAR and can be accessed at www.sedar.com. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content:https://www.prnewswire.com/news-releases/atmofizer-technologies-inc-announces-fox-news-interviews-with-board-member-dr-joshua-helman-301870377.html

SOURCE Atmofizer Technologies Inc.